Development of Novel 3D Spheroids for Discrete Subaortic Stenosis

In this study, we propose a new method for bioprinting 3D Spheroids to study complex congenital heart disease known as discrete subaortic stenosis (DSS). The bioprinter allows us to manipulate the extrusion pressure to change the size of the spheroids, and the alginate porosity increases in size ove...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular engineering and technology 2024-12, Vol.15 (6), p.704-715
Main Authors: Brimmer, Sunita, Ji, Pengfei, Birla, Ravi K., Heinle, Jeffrey S., Grande-Allen, Jane K., Keswani, Sundeep G.
Format: Article
Language:English
Subjects:
Alginates
Biomedical and Life Sciences
Biomedical Engineering and Bioengineering
Biomedical Engineering/Biotechnology
Biomedicine
Bioprinting
Cardiology
Cell Survival - drug effects
Cells, Cultured
Discrete Subaortic Stenosis - pathology
Discrete Subaortic Stenosis - physiopathology
Human Umbilical Vein Endothelial Cells - metabolism
Human Umbilical Vein Endothelial Cells - pathology
Humans
Original Article
Poloxamer - pharmacology
Porosity
Printing, Three-Dimensional
Spheroids, Cellular - pathology
Time Factors
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this study, we propose a new method for bioprinting 3D Spheroids to study complex congenital heart disease known as discrete subaortic stenosis (DSS). The bioprinter allows us to manipulate the extrusion pressure to change the size of the spheroids, and the alginate porosity increases in size over time. The spheroids are composed of human umbilical vein endothelial cells (HUVECs), and we demonstrated that pressure and time during the bioprinting process can modulate the diameter of the spheroids. In addition, we used Pluronic acid to maintain the shape and position of the spheroids. Characterization of HUVECs in the spheroids confirmed their uniform distribution and we demonstrated cell viability as a function of time. Compared to traditional 2D cell cultures, the 3D spheroids model provides more relevant physiological environments, making it valuable for drug testing and therapeutic applications.
ISSN:1869-408X
1869-4098
1869-4098
DOI:10.1007/s13239-024-00746-x